BioLargo says BLEST subsidiary awarded contract to assist in the reconfiguration of Regenerative Thermal Oxidizer systems at a large chemicals plant

BioLargo, Inc. has announced that its subsidiary BioLargo Engineering, Science & Technologies (BLEST) has been awarded a contract to assist in the reconfiguration of the Regenerative Thermal Oxidizer (RTO) systems used at a large chemical manufacturing plant on the East Coast of the US. The plant, owned by a global chemical company, produces phenolic resins, antioxidants and related synthetic organic products. The contract is expected to execute with a series of milestones through mid-2021, with anticipated scope expanding the contract period to at least 24 months and over $500,000 in total revenue, BioLargo said in a statement.